SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-028609
Filing Date
2016-11-09
Accepted
2016-11-09 16:03:06
Documents
64
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q akba-10q_20160930.htm 10-Q 1709097
2 EX-10.1 akba-ex101_14.htm EX-10.1 207084
3 EX-31.1 akba-ex311_7.htm EX-31.1 17375
4 EX-31.2 akba-ex312_8.htm EX-31.2 17391
5 EX-32.1 akba-ex321_9.htm EX-32.1 11888
6 EX-99.1 akba-ex991_6.htm EX-99.1 119424
7 GRAPHIC g20161108155434208105.jpg GRAPHIC 34587
8 GRAPHIC g20161108155434219106.jpg GRAPHIC 45892
9 GRAPHIC g2016110815543203190.jpg GRAPHIC 2066
  Complete submission text file 0001564590-16-028609.txt   7115650

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT akba-20160930.xml EX-101.INS 1584803
11 XBRL TAXONOMY EXTENSION SCHEMA akba-20160930.xsd EX-101.SCH 42382
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akba-20160930_cal.xml EX-101.CAL 47919
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akba-20160930_def.xml EX-101.DEF 143127
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE akba-20160930_lab.xml EX-101.LAB 329324
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akba-20160930_pre.xml EX-101.PRE 260982
Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36352 | Film No.: 161984192
SIC: 2834 Pharmaceutical Preparations